Structure Info
- Chemspace ID
- CSCS02495325989 (Synthesis)
- MFCD
- MFCD01941566
- IUPAC Name
- 3-[4-({[2,6-bis({[4-(2-aminoethoxy)quinolin-2-yl]carbamoyl})pyridin-4-yl]oxy}methyl)-1H-1,2,3-triazol-1-yl]propanoic acid; trifluoroacetic acid
- Mol formula
- C37H35F3N10O9
- Mol weight
- 821 Da
- Catalog Number(s)
- AA01EO0A, AG01EO32, AR01EOS2, AX63814, HY-112680A, MS-31523, T13595, Y3104982, ZXC382496
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.15
- Heavy atoms count
- 59
- Rotatable bond count
- 17
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.216
- Polar surface area (Å)
- 245
- Hydrogen bond acceptors count
- 14
- Hydrogen bond donors count
- 5
- Zoom the structure
- CSCS02495325989
Items Overall 11 items from 5 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 95 | 1 mg | 561 | |
Key Organics Limited (BIONET) | 10 days | United Kingdom To: | 95 | 5 mg | 1,115 | |
Angene US | 10 days | United States To: | 99 | 1 mg | 685 | |
Angene US | 10 days | United States To: | 99 | 5 mg | 1,410 | |
Angene US | 10 days | United States To: | 99 | 10 mg | 2,377 | |
Description: Carboxy pyridostatin trifluoroacetate salt; CAS: 2444713-88-4 | ||||||
AA BLOCKS | 35 days | United States To: | 90 | 1 mg | 424 | |
AA BLOCKS | 35 days | United States To: | 90 | 5 mg | 831 | |
AA BLOCKS | 35 days | United States To: | 90 | 10 mg | 1,374 | |
AA BLOCKS | 35 days | United States To: | 90 | 25 mg | 2,624 | |
Description: Carboxy pyridostatin trifluoroacetate salt; CAS: 2444713-88-4 | ||||||
Targetmol Chemicals Inc | TBD | United States To: | 90 | 1 mg | POA | |
Description: Carboxy pyridostatin trifluoroacetate salt exhibits higher molecular specificity for RNA over DNA G4s. | ||||||
Zerenex Molecular Ltd | TBD | United Kingdom To: | 95 | 1 g | POA | |
Description: CAS: 2444713-88-4 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire